EP3883606
Örugg og áhrifarík aðferð til meðhöndlunar á sáraristilbólgu með and-IL12/IL23-mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.9.2019EP published:
12.7.2023EP application number:
19867085.3
EP translation filed:
21.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
23.9.2039Expiry date:
23.9.2026Next due date:
30.9.2026
Title in English:
SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12/IL23 ANTIBODYLanguage of the patent:
English
Timeline
Today
24.9.2019EP application
12.7.2023EP Publication
21.8.2023Translation submitted
15.9.2023Registration published
23.9.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
JOHANNS, JewelAddress:
Spring House, Pennsylvania 19477, US
Name:
LI, KatherineAddress:
Spring House, Pennsylvania 19477, US
Name:
MARANO, ColleenAddress:
Spring House, Pennsylvania 19477, US
Name:
STRAUSS, RichardAddress:
Spring House, Pennsylvania 19477, US
Name:
ZHANG, HongyanAddress:
Spring House, Pennsylvania 19477, US
Name:
ADEDOKUN, OmoniyiAddress:
Spring House, Pennsylvania 19477, US
Name:
O'BRIEN, ChristopherAddress:
Spring House, Pennsylvania 19477, US
Name:
SHIELDS-TUTTLE, KimberlyAddress:
Spring House, Pennsylvania 19477, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862735501 PDate:
24.9.2018Country:
US
Number:
201862769818 PDate:
20.11.2018Country:
US
Number:
201962895774 PDate:
4.9.2019Country:
US
Classification
Categories:
A61K 39/395, C07K 14/54
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 29.9.2023
Expires: 23.9.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 7.8.2024
Expires: 23.9.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.9.2025
Expires: 23.9.2026
Payer: Árnason Faktor ehf.